Literature DB >> 7189201

Influence of adult thymectomy on immunocompetence in patients with myasthenia gravis.

P Wijermans, H J Oosterhuis, G C Astaldi, P T Schellekens, A Astaldi.   

Abstract

The influence of adult thymectomy on several parameters of immunocompetence in patients with myasthenia gravis (MG) was investigated. Since incomplete thymectomy may lead to the presence of thymic remnants, we determined the activity of a thymus-dependent factor in the sera of the MG patients. As measured by several parameters, MG patients showed a normal immunocompetence compared with healthy controls, except in the response to DNCB sensitization in vivo. When tested at least 5 years after thymectomy, MG patients were found to have decreased response to mitogens, and a decreased cytotoxic T cell response in cell-mediated lympholysis. The response to challenge with DNCB in vivo was decreased both in thymectomized and nonthymectomized MG patients. No difference was found in a) the percentage of circulating T, B, non-B/non-T cells; b) the response to allogeneic cells (MLR); c) the antibody-dependent lymphocytotoxicity; d) the production of immunoglobulins in vitro by pokeweed mitogen-stimulated cells; and e) the anamnestic response to antigens in vitro. We conclude that adult thymectomy results in a decrease in the function of some subpopulations of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189201

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

Authors:  J B Kuks; P C Limburg; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

2.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

Review 3.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Specific involvement of peripheral T lymphocytes against acetylcholine receptors in myasthenia gravis.

Authors:  B M Conti-Tronconi; A Scotti; A Sghirlanzoni; F Clementi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-09       Impact factor: 10.154

5.  Lymphocyte populations in patients with myasthenia gravis. Influence of thymectomy and immunosuppressive drugs.

Authors:  G Ippoliti; G Piccolo; M Lombardi; G Carnevale Maffé; V Cosi; P Pinelli
Journal:  Ital J Neurol Sci       Date:  1982-12

6.  Changes in human T lymphocytes after thymectomy and during senescence.

Authors:  R J Van de Griend; M Carreno; R Van Doorn; C J Leupers; A Van den Ende; P Wijermans; H J Oosterhuis; A Astaldi
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

7.  Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.

Authors:  S Berrih; C Gaud; M A Bach; H Le Brigand; J P Binet; J F Bach
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

8.  Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapy.

Authors:  Ramy M Hanna; Farid Arman; Umut Selamet; William D Wallace; Marina Barsoum; Anjay Rastogi; Niloofar Nobakht; Perry Shieh
Journal:  SAGE Open Med Case Rep       Date:  2019-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.